nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Clonidine—SLC22A4—rheumatoid arthritis	0.00945	1	CrCbGaD
Apraclonidine—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.00113	0.00145	CcSEcCtD
Apraclonidine—Ill-defined disorder—Triamcinolone—rheumatoid arthritis	0.00113	0.00145	CcSEcCtD
Apraclonidine—Ill-defined disorder—Methylprednisolone—rheumatoid arthritis	0.00112	0.00145	CcSEcCtD
Apraclonidine—Bradycardia—Prednisone—rheumatoid arthritis	0.00112	0.00144	CcSEcCtD
Apraclonidine—Diarrhoea—Azathioprine—rheumatoid arthritis	0.00111	0.00143	CcSEcCtD
Apraclonidine—Discomfort—Prednisolone—rheumatoid arthritis	0.00111	0.00143	CcSEcCtD
Apraclonidine—Abdominal discomfort—Methotrexate—rheumatoid arthritis	0.0011	0.00142	CcSEcCtD
Apraclonidine—Haemorrhage—Prednisone—rheumatoid arthritis	0.0011	0.00142	CcSEcCtD
Apraclonidine—Erythema—Betamethasone—rheumatoid arthritis	0.0011	0.00142	CcSEcCtD
Apraclonidine—Erythema—Dexamethasone—rheumatoid arthritis	0.0011	0.00142	CcSEcCtD
Apraclonidine—Asthenia—Leflunomide—rheumatoid arthritis	0.0011	0.00142	CcSEcCtD
Apraclonidine—Myalgia—Hydrocortisone—rheumatoid arthritis	0.0011	0.00141	CcSEcCtD
Apraclonidine—Malaise—Triamcinolone—rheumatoid arthritis	0.00109	0.00141	CcSEcCtD
Apraclonidine—Malaise—Methylprednisolone—rheumatoid arthritis	0.00109	0.0014	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.00109	0.0014	CcSEcCtD
Apraclonidine—Syncope—Triamcinolone—rheumatoid arthritis	0.00109	0.0014	CcSEcCtD
Apraclonidine—Syncope—Methylprednisolone—rheumatoid arthritis	0.00109	0.0014	CcSEcCtD
Apraclonidine—Pruritus—Leflunomide—rheumatoid arthritis	0.00108	0.0014	CcSEcCtD
Apraclonidine—Discomfort—Hydrocortisone—rheumatoid arthritis	0.00108	0.00139	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.00108	0.00139	CcSEcCtD
Apraclonidine—Oedema—Prednisolone—rheumatoid arthritis	0.00108	0.00139	CcSEcCtD
Apraclonidine—Dizziness—Azathioprine—rheumatoid arthritis	0.00107	0.00138	CcSEcCtD
Apraclonidine—Insomnia—Cyclosporine—rheumatoid arthritis	0.00107	0.00138	CcSEcCtD
Apraclonidine—Paraesthesia—Cyclosporine—rheumatoid arthritis	0.00106	0.00137	CcSEcCtD
Apraclonidine—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.00105	0.00136	CcSEcCtD
Apraclonidine—Somnolence—Cyclosporine—rheumatoid arthritis	0.00105	0.00135	CcSEcCtD
Apraclonidine—Oedema—Hydrocortisone—rheumatoid arthritis	0.00105	0.00135	CcSEcCtD
Apraclonidine—Diarrhoea—Leflunomide—rheumatoid arthritis	0.00105	0.00135	CcSEcCtD
Apraclonidine—Infection—Hydrocortisone—rheumatoid arthritis	0.00104	0.00134	CcSEcCtD
Apraclonidine—Myalgia—Triamcinolone—rheumatoid arthritis	0.00103	0.00133	CcSEcCtD
Apraclonidine—Vomiting—Azathioprine—rheumatoid arthritis	0.00103	0.00133	CcSEcCtD
Apraclonidine—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.00103	0.00133	CcSEcCtD
Apraclonidine—Myalgia—Methylprednisolone—rheumatoid arthritis	0.00103	0.00133	CcSEcCtD
Apraclonidine—Eye disorder—Prednisone—rheumatoid arthritis	0.00103	0.00132	CcSEcCtD
Apraclonidine—Infestation NOS—Methotrexate—rheumatoid arthritis	0.00103	0.00132	CcSEcCtD
Apraclonidine—Infestation—Methotrexate—rheumatoid arthritis	0.00103	0.00132	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.00102	0.00132	CcSEcCtD
Apraclonidine—Dermatitis—Azathioprine—rheumatoid arthritis	0.00102	0.00132	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.00102	0.00131	CcSEcCtD
Apraclonidine—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.00102	0.00131	CcSEcCtD
Apraclonidine—Ill-defined disorder—Betamethasone—rheumatoid arthritis	0.00102	0.00131	CcSEcCtD
Apraclonidine—Ill-defined disorder—Dexamethasone—rheumatoid arthritis	0.00102	0.00131	CcSEcCtD
Apraclonidine—Discomfort—Triamcinolone—rheumatoid arthritis	0.00102	0.00131	CcSEcCtD
Apraclonidine—Fatigue—Cyclosporine—rheumatoid arthritis	0.00102	0.00131	CcSEcCtD
Apraclonidine—Discomfort—Methylprednisolone—rheumatoid arthritis	0.00102	0.00131	CcSEcCtD
Apraclonidine—Headache—Azathioprine—rheumatoid arthritis	0.00102	0.00131	CcSEcCtD
Apraclonidine—Dizziness—Leflunomide—rheumatoid arthritis	0.00101	0.0013	CcSEcCtD
Apraclonidine—Pain—Cyclosporine—rheumatoid arthritis	0.00101	0.0013	CcSEcCtD
Apraclonidine—Constipation—Cyclosporine—rheumatoid arthritis	0.00101	0.0013	CcSEcCtD
Apraclonidine—Dry mouth—Triamcinolone—rheumatoid arthritis	0.00101	0.0013	CcSEcCtD
Apraclonidine—Angiopathy—Prednisone—rheumatoid arthritis	0.000999	0.00129	CcSEcCtD
Apraclonidine—Conjunctivitis—Methotrexate—rheumatoid arthritis	0.000996	0.00128	CcSEcCtD
Apraclonidine—Malaise—Dexamethasone—rheumatoid arthritis	0.000993	0.00128	CcSEcCtD
Apraclonidine—Malaise—Betamethasone—rheumatoid arthritis	0.000993	0.00128	CcSEcCtD
Apraclonidine—Oedema—Triamcinolone—rheumatoid arthritis	0.00099	0.00127	CcSEcCtD
Apraclonidine—Syncope—Dexamethasone—rheumatoid arthritis	0.000987	0.00127	CcSEcCtD
Apraclonidine—Syncope—Betamethasone—rheumatoid arthritis	0.000987	0.00127	CcSEcCtD
Apraclonidine—Arrhythmia—Prednisone—rheumatoid arthritis	0.000984	0.00127	CcSEcCtD
Apraclonidine—Infection—Triamcinolone—rheumatoid arthritis	0.000984	0.00127	CcSEcCtD
Apraclonidine—Infection—Methylprednisolone—rheumatoid arthritis	0.000981	0.00126	CcSEcCtD
Apraclonidine—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000975	0.00125	CcSEcCtD
Apraclonidine—Vomiting—Leflunomide—rheumatoid arthritis	0.000975	0.00125	CcSEcCtD
Apraclonidine—Insomnia—Prednisolone—rheumatoid arthritis	0.000974	0.00125	CcSEcCtD
Apraclonidine—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000969	0.00125	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000967	0.00125	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000967	0.00124	CcSEcCtD
Apraclonidine—Dermatitis—Leflunomide—rheumatoid arthritis	0.000966	0.00124	CcSEcCtD
Apraclonidine—Mental disorder—Prednisone—rheumatoid arthritis	0.000965	0.00124	CcSEcCtD
Apraclonidine—Nausea—Azathioprine—rheumatoid arthritis	0.000964	0.00124	CcSEcCtD
Apraclonidine—Headache—Leflunomide—rheumatoid arthritis	0.00096	0.00124	CcSEcCtD
Apraclonidine—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000959	0.00123	CcSEcCtD
Apraclonidine—Erythema—Prednisone—rheumatoid arthritis	0.000958	0.00123	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000958	0.00123	CcSEcCtD
Apraclonidine—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000951	0.00122	CcSEcCtD
Apraclonidine—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000944	0.00122	CcSEcCtD
Apraclonidine—Myalgia—Betamethasone—rheumatoid arthritis	0.000937	0.00121	CcSEcCtD
Apraclonidine—Myalgia—Dexamethasone—rheumatoid arthritis	0.000937	0.00121	CcSEcCtD
Apraclonidine—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000935	0.0012	CcSEcCtD
Apraclonidine—Discomfort—Betamethasone—rheumatoid arthritis	0.000926	0.00119	CcSEcCtD
Apraclonidine—Discomfort—Dexamethasone—rheumatoid arthritis	0.000926	0.00119	CcSEcCtD
Apraclonidine—Pain—Prednisolone—rheumatoid arthritis	0.000921	0.00118	CcSEcCtD
Apraclonidine—Haemorrhage—Methotrexate—rheumatoid arthritis	0.00092	0.00118	CcSEcCtD
Apraclonidine—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000913	0.00118	CcSEcCtD
Apraclonidine—Nausea—Leflunomide—rheumatoid arthritis	0.000911	0.00117	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000908	0.00117	CcSEcCtD
Apraclonidine—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000906	0.00117	CcSEcCtD
Apraclonidine—Vision blurred—Prednisone—rheumatoid arthritis	0.000903	0.00116	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000902	0.00116	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.0009	0.00116	CcSEcCtD
Apraclonidine—Pain—Hydrocortisone—rheumatoid arthritis	0.000899	0.00116	CcSEcCtD
Apraclonidine—Oedema—Dexamethasone—rheumatoid arthritis	0.000898	0.00116	CcSEcCtD
Apraclonidine—Oedema—Betamethasone—rheumatoid arthritis	0.000898	0.00116	CcSEcCtD
Apraclonidine—Insomnia—Triamcinolone—rheumatoid arthritis	0.000895	0.00115	CcSEcCtD
Apraclonidine—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000893	0.00115	CcSEcCtD
Apraclonidine—Infection—Betamethasone—rheumatoid arthritis	0.000892	0.00115	CcSEcCtD
Apraclonidine—Infection—Dexamethasone—rheumatoid arthritis	0.000892	0.00115	CcSEcCtD
Apraclonidine—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000889	0.00114	CcSEcCtD
Apraclonidine—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000889	0.00114	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000887	0.00114	CcSEcCtD
Apraclonidine—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000887	0.00114	CcSEcCtD
Apraclonidine—Visual impairment—Methotrexate—rheumatoid arthritis	0.000887	0.00114	CcSEcCtD
Apraclonidine—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000883	0.00114	CcSEcCtD
Apraclonidine—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000881	0.00113	CcSEcCtD
Apraclonidine—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000881	0.00113	CcSEcCtD
Apraclonidine—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000872	0.00112	CcSEcCtD
Apraclonidine—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000866	0.00112	CcSEcCtD
Apraclonidine—Malaise—Prednisone—rheumatoid arthritis	0.000864	0.00111	CcSEcCtD
Apraclonidine—Eye disorder—Methotrexate—rheumatoid arthritis	0.00086	0.00111	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.00086	0.00111	CcSEcCtD
Apraclonidine—Syncope—Prednisone—rheumatoid arthritis	0.00086	0.00111	CcSEcCtD
Apraclonidine—Fatigue—Triamcinolone—rheumatoid arthritis	0.000854	0.0011	CcSEcCtD
Apraclonidine—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000852	0.0011	CcSEcCtD
Apraclonidine—Asthenia—Cyclosporine—rheumatoid arthritis	0.000849	0.00109	CcSEcCtD
Apraclonidine—Pain—Triamcinolone—rheumatoid arthritis	0.000847	0.00109	CcSEcCtD
Apraclonidine—Pruritus—Cyclosporine—rheumatoid arthritis	0.000837	0.00108	CcSEcCtD
Apraclonidine—Angiopathy—Methotrexate—rheumatoid arthritis	0.000835	0.00107	CcSEcCtD
Apraclonidine—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000831	0.00107	CcSEcCtD
Apraclonidine—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000829	0.00107	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000818	0.00105	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000818	0.00105	CcSEcCtD
Apraclonidine—Myalgia—Prednisone—rheumatoid arthritis	0.000816	0.00105	CcSEcCtD
Apraclonidine—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000816	0.00105	CcSEcCtD
Apraclonidine—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000814	0.00105	CcSEcCtD
Apraclonidine—Insomnia—Betamethasone—rheumatoid arthritis	0.000812	0.00105	CcSEcCtD
Apraclonidine—Insomnia—Dexamethasone—rheumatoid arthritis	0.000812	0.00105	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.00081	0.00104	CcSEcCtD
Apraclonidine—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000809	0.00104	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000808	0.00104	CcSEcCtD
Apraclonidine—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000807	0.00104	CcSEcCtD
Apraclonidine—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000807	0.00104	CcSEcCtD
Apraclonidine—Discomfort—Prednisone—rheumatoid arthritis	0.000806	0.00104	CcSEcCtD
Apraclonidine—Mental disorder—Methotrexate—rheumatoid arthritis	0.000806	0.00104	CcSEcCtD
Apraclonidine—Erythema—Methotrexate—rheumatoid arthritis	0.000801	0.00103	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000793	0.00102	CcSEcCtD
Apraclonidine—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000784	0.00101	CcSEcCtD
Apraclonidine—Dizziness—Cyclosporine—rheumatoid arthritis	0.000782	0.00101	CcSEcCtD
Apraclonidine—Oedema—Prednisone—rheumatoid arthritis	0.000782	0.00101	CcSEcCtD
Apraclonidine—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000781	0.001	CcSEcCtD
Apraclonidine—Infection—Prednisone—rheumatoid arthritis	0.000777	0.001	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000775	0.000998	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000775	0.000998	CcSEcCtD
Apraclonidine—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000775	0.000997	CcSEcCtD
Apraclonidine—Fatigue—Betamethasone—rheumatoid arthritis	0.000774	0.000997	CcSEcCtD
Apraclonidine—Fatigue—Dexamethasone—rheumatoid arthritis	0.000774	0.000997	CcSEcCtD
Apraclonidine—Pain—Dexamethasone—rheumatoid arthritis	0.000768	0.000989	CcSEcCtD
Apraclonidine—Pain—Betamethasone—rheumatoid arthritis	0.000768	0.000989	CcSEcCtD
Apraclonidine—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000767	0.000987	CcSEcCtD
Apraclonidine—Skin disorder—Prednisone—rheumatoid arthritis	0.00076	0.000978	CcSEcCtD
Apraclonidine—Vision blurred—Methotrexate—rheumatoid arthritis	0.000755	0.000972	CcSEcCtD
Apraclonidine—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000754	0.000971	CcSEcCtD
Apraclonidine—Vomiting—Cyclosporine—rheumatoid arthritis	0.000752	0.000968	CcSEcCtD
Apraclonidine—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000745	0.000959	CcSEcCtD
Apraclonidine—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000744	0.000957	CcSEcCtD
Apraclonidine—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000743	0.000957	CcSEcCtD
Apraclonidine—Headache—Cyclosporine—rheumatoid arthritis	0.000741	0.000954	CcSEcCtD
Apraclonidine—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.00074	0.000953	CcSEcCtD
Apraclonidine—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.00074	0.000953	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000735	0.000945	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000735	0.000945	CcSEcCtD
Apraclonidine—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000729	0.000939	CcSEcCtD
Apraclonidine—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000728	0.000937	CcSEcCtD
Apraclonidine—Malaise—Methotrexate—rheumatoid arthritis	0.000722	0.00093	CcSEcCtD
Apraclonidine—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000719	0.000926	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000713	0.000917	CcSEcCtD
Apraclonidine—Dizziness—Prednisolone—rheumatoid arthritis	0.000712	0.000916	CcSEcCtD
Apraclonidine—Asthenia—Triamcinolone—rheumatoid arthritis	0.00071	0.000914	CcSEcCtD
Apraclonidine—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.00071	0.000914	CcSEcCtD
Apraclonidine—Abdominal pain—Betamethasone—rheumatoid arthritis	0.00071	0.000914	CcSEcCtD
Apraclonidine—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000709	0.000912	CcSEcCtD
Apraclonidine—Insomnia—Prednisone—rheumatoid arthritis	0.000708	0.000911	CcSEcCtD
Apraclonidine—Nausea—Cyclosporine—rheumatoid arthritis	0.000703	0.000904	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisone—rheumatoid arthritis	0.000702	0.000904	CcSEcCtD
Apraclonidine—Pruritus—Triamcinolone—rheumatoid arthritis	0.0007	0.000901	CcSEcCtD
Apraclonidine—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000699	0.000899	CcSEcCtD
Apraclonidine—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000695	0.000895	CcSEcCtD
Apraclonidine—Myalgia—Methotrexate—rheumatoid arthritis	0.000682	0.000878	CcSEcCtD
Apraclonidine—Chest pain—Methotrexate—rheumatoid arthritis	0.000682	0.000878	CcSEcCtD
Apraclonidine—Dermatitis—Prednisolone—rheumatoid arthritis	0.000678	0.000873	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000677	0.000872	CcSEcCtD
Apraclonidine—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000676	0.00087	CcSEcCtD
Apraclonidine—Fatigue—Prednisone—rheumatoid arthritis	0.000674	0.000868	CcSEcCtD
Apraclonidine—Headache—Prednisolone—rheumatoid arthritis	0.000674	0.000868	CcSEcCtD
Apraclonidine—Discomfort—Methotrexate—rheumatoid arthritis	0.000674	0.000867	CcSEcCtD
Apraclonidine—Constipation—Prednisone—rheumatoid arthritis	0.000669	0.000861	CcSEcCtD
Apraclonidine—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000668	0.00086	CcSEcCtD
Apraclonidine—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000662	0.000852	CcSEcCtD
Apraclonidine—Headache—Hydrocortisone—rheumatoid arthritis	0.000659	0.000848	CcSEcCtD
Apraclonidine—Dizziness—Triamcinolone—rheumatoid arthritis	0.000655	0.000843	CcSEcCtD
Apraclonidine—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000653	0.000841	CcSEcCtD
Apraclonidine—Infection—Methotrexate—rheumatoid arthritis	0.000649	0.000836	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000645	0.00083	CcSEcCtD
Apraclonidine—Asthenia—Dexamethasone—rheumatoid arthritis	0.000644	0.000829	CcSEcCtD
Apraclonidine—Asthenia—Betamethasone—rheumatoid arthritis	0.000644	0.000829	CcSEcCtD
Apraclonidine—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000641	0.000825	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.00064	0.000823	CcSEcCtD
Apraclonidine—Nausea—Prednisolone—rheumatoid arthritis	0.000639	0.000823	CcSEcCtD
Apraclonidine—Pruritus—Betamethasone—rheumatoid arthritis	0.000636	0.000818	CcSEcCtD
Apraclonidine—Pruritus—Dexamethasone—rheumatoid arthritis	0.000636	0.000818	CcSEcCtD
Apraclonidine—Skin disorder—Methotrexate—rheumatoid arthritis	0.000635	0.000817	CcSEcCtD
Apraclonidine—Vomiting—Triamcinolone—rheumatoid arthritis	0.000629	0.00081	CcSEcCtD
Apraclonidine—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000628	0.000808	CcSEcCtD
Apraclonidine—Nausea—Hydrocortisone—rheumatoid arthritis	0.000624	0.000804	CcSEcCtD
Apraclonidine—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000624	0.000803	CcSEcCtD
Apraclonidine—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000622	0.000801	CcSEcCtD
Apraclonidine—Headache—Triamcinolone—rheumatoid arthritis	0.00062	0.000798	CcSEcCtD
Apraclonidine—Headache—Methylprednisolone—rheumatoid arthritis	0.000619	0.000796	CcSEcCtD
Apraclonidine—Abdominal pain—Prednisone—rheumatoid arthritis	0.000618	0.000796	CcSEcCtD
Apraclonidine—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000615	0.000791	CcSEcCtD
Apraclonidine—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000615	0.000791	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000596	0.000767	CcSEcCtD
Apraclonidine—Dizziness—Betamethasone—rheumatoid arthritis	0.000594	0.000764	CcSEcCtD
Apraclonidine—Dizziness—Dexamethasone—rheumatoid arthritis	0.000594	0.000764	CcSEcCtD
Apraclonidine—Insomnia—Methotrexate—rheumatoid arthritis	0.000591	0.000761	CcSEcCtD
Apraclonidine—Nausea—Triamcinolone—rheumatoid arthritis	0.000588	0.000757	CcSEcCtD
Apraclonidine—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000587	0.000756	CcSEcCtD
Apraclonidine—Nausea—Methylprednisolone—rheumatoid arthritis	0.000587	0.000755	CcSEcCtD
Apraclonidine—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000583	0.00075	CcSEcCtD
Apraclonidine—Somnolence—Methotrexate—rheumatoid arthritis	0.000581	0.000748	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000576	0.000742	CcSEcCtD
Apraclonidine—Vomiting—Dexamethasone—rheumatoid arthritis	0.000571	0.000735	CcSEcCtD
Apraclonidine—Vomiting—Betamethasone—rheumatoid arthritis	0.000571	0.000735	CcSEcCtD
Apraclonidine—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000566	0.000728	CcSEcCtD
Apraclonidine—Dermatitis—Betamethasone—rheumatoid arthritis	0.000566	0.000728	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000564	0.000726	CcSEcCtD
Apraclonidine—Fatigue—Methotrexate—rheumatoid arthritis	0.000564	0.000725	CcSEcCtD
Apraclonidine—Headache—Dexamethasone—rheumatoid arthritis	0.000563	0.000724	CcSEcCtD
Apraclonidine—Headache—Betamethasone—rheumatoid arthritis	0.000563	0.000724	CcSEcCtD
Apraclonidine—Asthenia—Prednisone—rheumatoid arthritis	0.000561	0.000722	CcSEcCtD
Apraclonidine—Pain—Methotrexate—rheumatoid arthritis	0.000559	0.00072	CcSEcCtD
Apraclonidine—Pruritus—Prednisone—rheumatoid arthritis	0.000553	0.000712	CcSEcCtD
Apraclonidine—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000539	0.000693	CcSEcCtD
Apraclonidine—Diarrhoea—Prednisone—rheumatoid arthritis	0.000535	0.000689	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000535	0.000688	CcSEcCtD
Apraclonidine—Nausea—Dexamethasone—rheumatoid arthritis	0.000534	0.000687	CcSEcCtD
Apraclonidine—Nausea—Betamethasone—rheumatoid arthritis	0.000534	0.000687	CcSEcCtD
Apraclonidine—Dizziness—Prednisone—rheumatoid arthritis	0.000517	0.000666	CcSEcCtD
Apraclonidine—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000517	0.000665	CcSEcCtD
Apraclonidine—Vomiting—Prednisone—rheumatoid arthritis	0.000497	0.00064	CcSEcCtD
Apraclonidine—Dermatitis—Prednisone—rheumatoid arthritis	0.000493	0.000634	CcSEcCtD
Apraclonidine—Headache—Prednisone—rheumatoid arthritis	0.00049	0.000631	CcSEcCtD
Apraclonidine—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000482	0.00062	CcSEcCtD
Apraclonidine—Asthenia—Methotrexate—rheumatoid arthritis	0.000469	0.000604	CcSEcCtD
Apraclonidine—Nausea—Prednisone—rheumatoid arthritis	0.000465	0.000598	CcSEcCtD
Apraclonidine—Pruritus—Methotrexate—rheumatoid arthritis	0.000463	0.000595	CcSEcCtD
Apraclonidine—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000447	0.000576	CcSEcCtD
Apraclonidine—Dizziness—Methotrexate—rheumatoid arthritis	0.000432	0.000556	CcSEcCtD
Apraclonidine—Vomiting—Methotrexate—rheumatoid arthritis	0.000416	0.000535	CcSEcCtD
Apraclonidine—Dermatitis—Methotrexate—rheumatoid arthritis	0.000412	0.00053	CcSEcCtD
Apraclonidine—Headache—Methotrexate—rheumatoid arthritis	0.00041	0.000527	CcSEcCtD
Apraclonidine—Nausea—Methotrexate—rheumatoid arthritis	0.000388	0.0005	CcSEcCtD
Apraclonidine—ADRA2C—Signaling Pathways—NCF1—rheumatoid arthritis	9.27e-05	0.000434	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL5—rheumatoid arthritis	9.27e-05	0.000434	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCR6—rheumatoid arthritis	9.25e-05	0.000433	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—NOS3—rheumatoid arthritis	9.21e-05	0.000431	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CCR5—rheumatoid arthritis	9.19e-05	0.00043	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—C5—rheumatoid arthritis	9.14e-05	0.000428	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CXCL8—rheumatoid arthritis	9.14e-05	0.000428	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CSF2—rheumatoid arthritis	9.13e-05	0.000427	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—MMP3—rheumatoid arthritis	9.12e-05	0.000427	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—IL2RA—rheumatoid arthritis	9.06e-05	0.000424	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NCF2—rheumatoid arthritis	9e-05	0.000421	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NFATC1—rheumatoid arthritis	9e-05	0.000421	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—UBE2D1—rheumatoid arthritis	8.99e-05	0.000421	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—C3—rheumatoid arthritis	8.98e-05	0.000421	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CD28—rheumatoid arthritis	8.92e-05	0.000417	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ENO1—rheumatoid arthritis	8.91e-05	0.000417	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCL12—rheumatoid arthritis	8.81e-05	0.000413	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—BDKRB2—rheumatoid arthritis	8.81e-05	0.000413	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—POMC—rheumatoid arthritis	8.8e-05	0.000412	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SH2B3—rheumatoid arthritis	8.77e-05	0.000411	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TRAF6—rheumatoid arthritis	8.77e-05	0.000411	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—VEGFA—rheumatoid arthritis	8.75e-05	0.00041	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL6ST—rheumatoid arthritis	8.74e-05	0.000409	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—GZMB—rheumatoid arthritis	8.72e-05	0.000408	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ADRBK1—rheumatoid arthritis	8.71e-05	0.000408	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL5—rheumatoid arthritis	8.61e-05	0.000403	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCR6—rheumatoid arthritis	8.6e-05	0.000403	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CCR5—rheumatoid arthritis	8.54e-05	0.0004	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CSF2—rheumatoid arthritis	8.48e-05	0.000397	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL3—rheumatoid arthritis	8.46e-05	0.000396	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL2—rheumatoid arthritis	8.46e-05	0.000396	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—IL2RA—rheumatoid arthritis	8.42e-05	0.000394	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—UBE2D1—rheumatoid arthritis	8.39e-05	0.000393	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NCF2—rheumatoid arthritis	8.36e-05	0.000392	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCR5—rheumatoid arthritis	8.35e-05	0.000391	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—C3—rheumatoid arthritis	8.35e-05	0.000391	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SAA1—rheumatoid arthritis	8.28e-05	0.000388	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCL12—rheumatoid arthritis	8.23e-05	0.000385	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—BDKRB2—rheumatoid arthritis	8.23e-05	0.000385	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL2RA—rheumatoid arthritis	8.23e-05	0.000385	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—POMC—rheumatoid arthritis	8.22e-05	0.000385	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—RASGRP1—rheumatoid arthritis	8.22e-05	0.000385	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—SYK—rheumatoid arthritis	8.19e-05	0.000384	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—VEGFA—rheumatoid arthritis	8.17e-05	0.000383	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL6ST—rheumatoid arthritis	8.16e-05	0.000382	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—C3—rheumatoid arthritis	8.16e-05	0.000382	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SH2B3—rheumatoid arthritis	8.15e-05	0.000382	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TRAF6—rheumatoid arthritis	8.15e-05	0.000382	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ADRBK1—rheumatoid arthritis	8.14e-05	0.000381	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NCF1—rheumatoid arthritis	8.1e-05	0.000379	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—GZMB—rheumatoid arthritis	8.1e-05	0.000379	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PRKCQ—rheumatoid arthritis	8.04e-05	0.000377	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—TGFB1—rheumatoid arthritis	8.03e-05	0.000376	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—POMC—rheumatoid arthritis	7.99e-05	0.000374	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CAT—rheumatoid arthritis	7.9e-05	0.00037	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—STAT1—rheumatoid arthritis	7.9e-05	0.00037	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL2—rheumatoid arthritis	7.86e-05	0.000368	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL3—rheumatoid arthritis	7.86e-05	0.000368	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCL2—rheumatoid arthritis	7.82e-05	0.000366	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IL2—rheumatoid arthritis	7.81e-05	0.000366	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL6R—rheumatoid arthritis	7.79e-05	0.000365	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CD28—rheumatoid arthritis	7.79e-05	0.000365	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCL10—rheumatoid arthritis	7.79e-05	0.000365	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCR5—rheumatoid arthritis	7.76e-05	0.000363	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SAA1—rheumatoid arthritis	7.69e-05	0.00036	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—RASGRP1—rheumatoid arthritis	7.68e-05	0.000359	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—SYK—rheumatoid arthritis	7.65e-05	0.000358	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL2RA—rheumatoid arthritis	7.64e-05	0.000358	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—C3—rheumatoid arthritis	7.58e-05	0.000355	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NCF1—rheumatoid arthritis	7.53e-05	0.000353	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PRKCQ—rheumatoid arthritis	7.51e-05	0.000352	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—TGFB1—rheumatoid arthritis	7.5e-05	0.000351	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—POMC—rheumatoid arthritis	7.46e-05	0.000349	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—STAT1—rheumatoid arthritis	7.38e-05	0.000346	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—UBE2D1—rheumatoid arthritis	7.34e-05	0.000344	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCL2—rheumatoid arthritis	7.3e-05	0.000342	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL6R—rheumatoid arthritis	7.28e-05	0.000341	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCL10—rheumatoid arthritis	7.27e-05	0.000341	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CD28—rheumatoid arthritis	7.24e-05	0.000339	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL12—rheumatoid arthritis	7.2e-05	0.000337	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—BDKRB2—rheumatoid arthritis	7.2e-05	0.000337	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—POMC—rheumatoid arthritis	7.19e-05	0.000336	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL6ST—rheumatoid arthritis	7.13e-05	0.000334	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ADRBK1—rheumatoid arthritis	7.12e-05	0.000333	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MMP3—rheumatoid arthritis	7.1e-05	0.000333	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—TYK2—rheumatoid arthritis	7.1e-05	0.000332	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PTK2—rheumatoid arthritis	6.84e-05	0.00032	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.82e-05	0.000319	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CXCL8—rheumatoid arthritis	6.81e-05	0.000319	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.71e-05	0.000314	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL5—rheumatoid arthritis	6.7e-05	0.000314	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SYK—rheumatoid arthritis	6.69e-05	0.000313	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.69e-05	0.000313	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL12—rheumatoid arthritis	6.69e-05	0.000313	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—POMC—rheumatoid arthritis	6.68e-05	0.000313	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—VEGFA—rheumatoid arthritis	6.64e-05	0.000311	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MMP3—rheumatoid arthritis	6.63e-05	0.000311	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—TYK2—rheumatoid arthritis	6.63e-05	0.000311	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL6ST—rheumatoid arthritis	6.63e-05	0.00031	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.61e-05	0.00031	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—TP53—rheumatoid arthritis	6.61e-05	0.000309	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CSF2—rheumatoid arthritis	6.6e-05	0.000309	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—MTHFR—rheumatoid arthritis	6.59e-05	0.000309	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PRKCQ—rheumatoid arthritis	6.57e-05	0.000307	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—POMC—rheumatoid arthritis	6.52e-05	0.000306	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—IL2—rheumatoid arthritis	6.5e-05	0.000305	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—STAT1—rheumatoid arthritis	6.45e-05	0.000302	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CAT—rheumatoid arthritis	6.42e-05	0.0003	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PTK2—rheumatoid arthritis	6.39e-05	0.000299	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL2—rheumatoid arthritis	6.38e-05	0.000299	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL6R—rheumatoid arthritis	6.36e-05	0.000298	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL10—rheumatoid arthritis	6.36e-05	0.000298	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CXCL8—rheumatoid arthritis	6.36e-05	0.000298	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL5—rheumatoid arthritis	6.26e-05	0.000293	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.24e-05	0.000292	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SYK—rheumatoid arthritis	6.22e-05	0.000291	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—SPP1—rheumatoid arthritis	6.21e-05	0.000291	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CXCL8—rheumatoid arthritis	6.18e-05	0.000289	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—TP53—rheumatoid arthritis	6.17e-05	0.000289	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CSF2—rheumatoid arthritis	6.17e-05	0.000289	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	6.1e-05	0.000286	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—TGFB1—rheumatoid arthritis	6.09e-05	0.000285	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—IL2—rheumatoid arthritis	6.08e-05	0.000285	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—POMC—rheumatoid arthritis	6.06e-05	0.000284	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCR5—rheumatoid arthritis	6.04e-05	0.000283	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—STAT1—rheumatoid arthritis	5.99e-05	0.000281	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL2RA—rheumatoid arthritis	5.95e-05	0.000279	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL2—rheumatoid arthritis	5.93e-05	0.000278	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL6R—rheumatoid arthritis	5.91e-05	0.000277	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL10—rheumatoid arthritis	5.91e-05	0.000277	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL2—rheumatoid arthritis	5.91e-05	0.000277	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—C3—rheumatoid arthritis	5.9e-05	0.000276	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MMP3—rheumatoid arthritis	5.8e-05	0.000272	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—SPP1—rheumatoid arthritis	5.8e-05	0.000272	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—TYK2—rheumatoid arthritis	5.8e-05	0.000271	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.77e-05	0.00027	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCR5—rheumatoid arthritis	5.64e-05	0.000264	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PTK2—rheumatoid arthritis	5.58e-05	0.000261	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL2RA—rheumatoid arthritis	5.56e-05	0.00026	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	5.56e-05	0.00026	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL2—rheumatoid arthritis	5.52e-05	0.000258	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—C3—rheumatoid arthritis	5.51e-05	0.000258	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—LEP—rheumatoid arthritis	5.49e-05	0.000257	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL5—rheumatoid arthritis	5.47e-05	0.000256	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CSF2—rheumatoid arthritis	5.39e-05	0.000252	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MMP3—rheumatoid arthritis	5.39e-05	0.000252	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—TYK2—rheumatoid arthritis	5.39e-05	0.000252	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—MTHFR—rheumatoid arthritis	5.36e-05	0.000251	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—IL2—rheumatoid arthritis	5.31e-05	0.000249	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—POMC—rheumatoid arthritis	5.27e-05	0.000247	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PTK2—rheumatoid arthritis	5.19e-05	0.000243	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—FN1—rheumatoid arthritis	5.18e-05	0.000243	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	5.16e-05	0.000242	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL6ST—rheumatoid arthritis	5.16e-05	0.000242	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—LEP—rheumatoid arthritis	5.13e-05	0.00024	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL5—rheumatoid arthritis	5.09e-05	0.000238	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SPP1—rheumatoid arthritis	5.07e-05	0.000237	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.05e-05	0.000236	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—TP53—rheumatoid arthritis	5.01e-05	0.000235	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CSF2—rheumatoid arthritis	5.01e-05	0.000235	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CD80—rheumatoid arthritis	4.97e-05	0.000233	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—IL2—rheumatoid arthritis	4.94e-05	0.000231	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCR5—rheumatoid arthritis	4.93e-05	0.000231	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL2RA—rheumatoid arthritis	4.86e-05	0.000228	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—FN1—rheumatoid arthritis	4.84e-05	0.000227	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL2—rheumatoid arthritis	4.82e-05	0.000226	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL6ST—rheumatoid arthritis	4.82e-05	0.000226	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—C3—rheumatoid arthritis	4.82e-05	0.000226	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ALB—rheumatoid arthritis	4.81e-05	0.000225	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—POMC—rheumatoid arthritis	4.72e-05	0.000221	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SPP1—rheumatoid arthritis	4.71e-05	0.000221	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.69e-05	0.00022	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CD80—rheumatoid arthritis	4.64e-05	0.000217	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL2—rheumatoid arthritis	4.62e-05	0.000216	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL6R—rheumatoid arthritis	4.6e-05	0.000216	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—NOS3—rheumatoid arthritis	4.6e-05	0.000215	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	4.58e-05	0.000215	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	4.52e-05	0.000211	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—LEP—rheumatoid arthritis	4.49e-05	0.00021	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	4.48e-05	0.00021	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	4.48e-05	0.00021	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—POMC—rheumatoid arthritis	4.41e-05	0.000206	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL2—rheumatoid arthritis	4.31e-05	0.000202	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL6R—rheumatoid arthritis	4.3e-05	0.000201	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—POMC—rheumatoid arthritis	4.28e-05	0.000201	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—FN1—rheumatoid arthritis	4.23e-05	0.000198	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL6ST—rheumatoid arthritis	4.21e-05	0.000197	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PTGS2—rheumatoid arthritis	4.21e-05	0.000197	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TYK2—rheumatoid arthritis	4.19e-05	0.000196	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	4.17e-05	0.000195	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NOS3—rheumatoid arthritis	4.12e-05	0.000193	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CD80—rheumatoid arthritis	4.06e-05	0.00019	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	3.93e-05	0.000184	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TYK2—rheumatoid arthritis	3.92e-05	0.000183	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	3.92e-05	0.000183	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ALB—rheumatoid arthritis	3.9e-05	0.000183	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—POMC—rheumatoid arthritis	3.85e-05	0.00018	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NOS3—rheumatoid arthritis	3.85e-05	0.00018	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL2—rheumatoid arthritis	3.77e-05	0.000177	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	3.77e-05	0.000176	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL6R—rheumatoid arthritis	3.76e-05	0.000176	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	3.74e-05	0.000175	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	3.65e-05	0.000171	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	3.58e-05	0.000168	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	3.5e-05	0.000164	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	3.49e-05	0.000164	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	3.49e-05	0.000163	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	3.47e-05	0.000163	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TYK2—rheumatoid arthritis	3.42e-05	0.00016	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	3.42e-05	0.00016	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCL8—rheumatoid arthritis	3.41e-05	0.00016	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NOS3—rheumatoid arthritis	3.36e-05	0.000157	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	3.3e-05	0.000155	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	3.27e-05	0.000153	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL2—rheumatoid arthritis	3.26e-05	0.000153	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL6—rheumatoid arthritis	3.24e-05	0.000152	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	3.21e-05	0.00015	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	3.18e-05	0.000149	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	3.12e-05	0.000146	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MMP9—rheumatoid arthritis	3.08e-05	0.000144	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NFKB1—rheumatoid arthritis	3.05e-05	0.000143	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MAPK8—rheumatoid arthritis	3e-05	0.00014	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL8—rheumatoid arthritis	2.98e-05	0.00014	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	2.97e-05	0.000139	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL2—rheumatoid arthritis	2.85e-05	0.000133	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL6—rheumatoid arthritis	2.84e-05	0.000133	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	2.77e-05	0.00013	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—VEGFA—rheumatoid arthritis	2.77e-05	0.00013	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	2.72e-05	0.000127	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MMP9—rheumatoid arthritis	2.7e-05	0.000126	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NFKB1—rheumatoid arthritis	2.67e-05	0.000125	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	2.65e-05	0.000124	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	2.63e-05	0.000123	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MAPK8—rheumatoid arthritis	2.62e-05	0.000123	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TGFB1—rheumatoid arthritis	2.54e-05	0.000119	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	2.51e-05	0.000117	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	2.48e-05	0.000116	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	2.44e-05	0.000114	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.42e-05	0.000113	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.25e-05	0.000105	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	2.24e-05	0.000105	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.22e-05	0.000104	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TP53—rheumatoid arthritis	2.09e-05	9.8e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.07e-05	9.67e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	2.05e-05	9.6e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL6—rheumatoid arthritis	1.92e-05	8.97e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TP53—rheumatoid arthritis	1.83e-05	8.57e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	1.7e-05	7.96e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL6—rheumatoid arthritis	1.67e-05	7.84e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	1.56e-05	7.29e-05	CbGpPWpGaD
